New EU anti-counterfeiting rules: comprehensive but costly
This article was originally published in Scrip
Executive Summary
New legislation on tackling the trade in falsified medicines has been given the green light by EU ministers, paving the way for novelties such as safety features on practically all prescription drug packs, a clampdown on internet sales, and closer supervision of manufacturing activities.